Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms.

Although the results of this trial should be interpreted with caution as they did not reach statistical significance, there was an 18% incidence of pneumonia with the anti-α-toxin mAb versus 26% with placebo ( P = 0.166).

also in 111,027 other papers